CDK modulators
A compound according to Formula I : or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHAN DIVA SZE-MING CHAN BRYAN JEONG JOON WON KIM MOON HWAN NOGUCHI ROBIN TAMMIE JONES LISA RENEE WANG YONG JAMMALAMADAKA VASU FORSYTH TIMOTHY PATRICK LEAHY JAMES W CHEN JEFF MAC MORRISON B RIDGWAY BRIAN HUGH FRANZINI MAURIZIO XU WEI RAO PALLAVI BAHCECI SULEYMAN KELLEY RYAN MICHAEL |
| description | A compound according to Formula I : or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN102143746A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN102143746A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN102143746A3</originalsourceid><addsrcrecordid>eNrjZOBzdvFWyM1PKc1JLMkvKuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGRoYmxuYmZo7GxKgBADvrHik</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CDK modulators</title><source>esp@cenet</source><creator>CHAN DIVA SZE-MING ; CHAN BRYAN ; JEONG JOON WON ; KIM MOON HWAN ; NOGUCHI ROBIN TAMMIE ; JONES LISA RENEE ; WANG YONG ; JAMMALAMADAKA VASU ; FORSYTH TIMOTHY PATRICK ; LEAHY JAMES W ; CHEN JEFF ; MAC MORRISON B ; RIDGWAY BRIAN HUGH ; FRANZINI MAURIZIO ; XU WEI ; RAO PALLAVI ; BAHCECI SULEYMAN ; KELLEY RYAN MICHAEL</creator><creatorcontrib>CHAN DIVA SZE-MING ; CHAN BRYAN ; JEONG JOON WON ; KIM MOON HWAN ; NOGUCHI ROBIN TAMMIE ; JONES LISA RENEE ; WANG YONG ; JAMMALAMADAKA VASU ; FORSYTH TIMOTHY PATRICK ; LEAHY JAMES W ; CHEN JEFF ; MAC MORRISON B ; RIDGWAY BRIAN HUGH ; FRANZINI MAURIZIO ; XU WEI ; RAO PALLAVI ; BAHCECI SULEYMAN ; KELLEY RYAN MICHAEL</creatorcontrib><description>A compound according to Formula I : or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110803&DB=EPODOC&CC=CN&NR=102143746A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110803&DB=EPODOC&CC=CN&NR=102143746A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAN DIVA SZE-MING</creatorcontrib><creatorcontrib>CHAN BRYAN</creatorcontrib><creatorcontrib>JEONG JOON WON</creatorcontrib><creatorcontrib>KIM MOON HWAN</creatorcontrib><creatorcontrib>NOGUCHI ROBIN TAMMIE</creatorcontrib><creatorcontrib>JONES LISA RENEE</creatorcontrib><creatorcontrib>WANG YONG</creatorcontrib><creatorcontrib>JAMMALAMADAKA VASU</creatorcontrib><creatorcontrib>FORSYTH TIMOTHY PATRICK</creatorcontrib><creatorcontrib>LEAHY JAMES W</creatorcontrib><creatorcontrib>CHEN JEFF</creatorcontrib><creatorcontrib>MAC MORRISON B</creatorcontrib><creatorcontrib>RIDGWAY BRIAN HUGH</creatorcontrib><creatorcontrib>FRANZINI MAURIZIO</creatorcontrib><creatorcontrib>XU WEI</creatorcontrib><creatorcontrib>RAO PALLAVI</creatorcontrib><creatorcontrib>BAHCECI SULEYMAN</creatorcontrib><creatorcontrib>KELLEY RYAN MICHAEL</creatorcontrib><title>CDK modulators</title><description>A compound according to Formula I : or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOBzdvFWyM1PKc1JLMkvKuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGRoYmxuYmZo7GxKgBADvrHik</recordid><startdate>20110803</startdate><enddate>20110803</enddate><creator>CHAN DIVA SZE-MING</creator><creator>CHAN BRYAN</creator><creator>JEONG JOON WON</creator><creator>KIM MOON HWAN</creator><creator>NOGUCHI ROBIN TAMMIE</creator><creator>JONES LISA RENEE</creator><creator>WANG YONG</creator><creator>JAMMALAMADAKA VASU</creator><creator>FORSYTH TIMOTHY PATRICK</creator><creator>LEAHY JAMES W</creator><creator>CHEN JEFF</creator><creator>MAC MORRISON B</creator><creator>RIDGWAY BRIAN HUGH</creator><creator>FRANZINI MAURIZIO</creator><creator>XU WEI</creator><creator>RAO PALLAVI</creator><creator>BAHCECI SULEYMAN</creator><creator>KELLEY RYAN MICHAEL</creator><scope>EVB</scope></search><sort><creationdate>20110803</creationdate><title>CDK modulators</title><author>CHAN DIVA SZE-MING ; CHAN BRYAN ; JEONG JOON WON ; KIM MOON HWAN ; NOGUCHI ROBIN TAMMIE ; JONES LISA RENEE ; WANG YONG ; JAMMALAMADAKA VASU ; FORSYTH TIMOTHY PATRICK ; LEAHY JAMES W ; CHEN JEFF ; MAC MORRISON B ; RIDGWAY BRIAN HUGH ; FRANZINI MAURIZIO ; XU WEI ; RAO PALLAVI ; BAHCECI SULEYMAN ; KELLEY RYAN MICHAEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN102143746A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHAN DIVA SZE-MING</creatorcontrib><creatorcontrib>CHAN BRYAN</creatorcontrib><creatorcontrib>JEONG JOON WON</creatorcontrib><creatorcontrib>KIM MOON HWAN</creatorcontrib><creatorcontrib>NOGUCHI ROBIN TAMMIE</creatorcontrib><creatorcontrib>JONES LISA RENEE</creatorcontrib><creatorcontrib>WANG YONG</creatorcontrib><creatorcontrib>JAMMALAMADAKA VASU</creatorcontrib><creatorcontrib>FORSYTH TIMOTHY PATRICK</creatorcontrib><creatorcontrib>LEAHY JAMES W</creatorcontrib><creatorcontrib>CHEN JEFF</creatorcontrib><creatorcontrib>MAC MORRISON B</creatorcontrib><creatorcontrib>RIDGWAY BRIAN HUGH</creatorcontrib><creatorcontrib>FRANZINI MAURIZIO</creatorcontrib><creatorcontrib>XU WEI</creatorcontrib><creatorcontrib>RAO PALLAVI</creatorcontrib><creatorcontrib>BAHCECI SULEYMAN</creatorcontrib><creatorcontrib>KELLEY RYAN MICHAEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAN DIVA SZE-MING</au><au>CHAN BRYAN</au><au>JEONG JOON WON</au><au>KIM MOON HWAN</au><au>NOGUCHI ROBIN TAMMIE</au><au>JONES LISA RENEE</au><au>WANG YONG</au><au>JAMMALAMADAKA VASU</au><au>FORSYTH TIMOTHY PATRICK</au><au>LEAHY JAMES W</au><au>CHEN JEFF</au><au>MAC MORRISON B</au><au>RIDGWAY BRIAN HUGH</au><au>FRANZINI MAURIZIO</au><au>XU WEI</au><au>RAO PALLAVI</au><au>BAHCECI SULEYMAN</au><au>KELLEY RYAN MICHAEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CDK modulators</title><date>2011-08-03</date><risdate>2011</risdate><abstract>A compound according to Formula I : or a pharmaceutically-acceptable salt thereof, wherein R1, R3, A, B and D are as defined in the specification; pharmaceutical compositions thereof, and methods of use thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN102143746A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CDK modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A50%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHAN%20DIVA%20SZE-MING&rft.date=2011-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN102143746A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |